Prevalence of Wild-Type Butyrylcholinesterase Genotype in Patients with Alzheimer’s Dementia

ISSN Print: 2162-2000
ISSN Online: 2162-2019
www.scirp.net/journal/wjns
E-mail: [email protected]

Citations

"Prevalence of Wild-Type Butyrylcholinesterase Genotype in Patients with Alzheimer’s Dementia"
written by Beate Mueller, Georg Adler,
published by World Journal of Neuroscience, Vol.5 No.3, 2015

has been cited by the following article(s):

[1]	A New Diagnostic Index Based on the Activity of Butyrylcholinesterase Isoforms for Laboratory Confirmation of Mild Cognitive Impairment Diagnosis
	Journal of Evolutionary …, 2022

[2]	Bitopic Ligands and their molecular fragments for the study of the M1 Muscarinic Receptor
	2021

[3]	О роли бутирилхолинэстеразы в патогенезе нейродегенеративных заболеваний: спорные аспекты
	2020

[4]	Benzofuran and indole: A promising scaffold for drug development in Alzheimer's disease
	ChemMedChem, 2018

[5]	Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer's Disease
	2018

[6]	Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Con cept to Treat Alzheimer's Disease.
	Molecules (Basel, Switzerland), 2018

[7]	Benzofuran and indole: promising scaffolds for drug development in Alzheimer's disease
	2018

[8]	Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's …
	… interventions in aging, 2017

[9]	Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and …
	Clinical interventions in aging, 2017

[10]	Hypocholinergic Stress and Neuronal Pruning in Alzheimer's Disease: A Theoretical Framework

[1]	A New Diagnostic Index Based on the Activity of Butyrylcholinesterase Isoforms for Laboratory Confirmation of Mild Cognitive Impairment Diagnosis Journal of Evolutionary Biochemistry and Physiology, 2022 DOI:10.1134/S002209302203022X

[2]	Benzofuran and Indole: Promising Scaffolds for Drug Development in Alzheimer's Disease ChemMedChem, 2018 DOI:10.1002/cmdc.201800156

[3]	Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer’s Disease Molecules, 2018 DOI:10.3390/molecules23123230